Recalls & Warnings May 01, 2023 TruVision Recalls Products Due to Presence of Potentially Dangerous Ingredients On April 27, 2023, TruVision Health issued a recall of various dietary supplement products because they contain hordenine and/or octodrine/DMHA, compounds that the FDA considers to be possibly unsafe and which are not permitted to be sold as dietary supplements
Stacking Context HCG is frequently documented alongside other axis-focused compounds rather than in isolation: Side Effects & Safety Reported effects, drawn from clinical and community sources: Estradiol elevation and related effects (water retention, moodiness) when doses are large or infrequent the reason community sources favor low, frequent IU dosing Injection-site reactions Acne or oily skin from increased androgen output Gynecomastia risk if estradiol is not managed HCG is a prescription hormone
BPC+TB Blend is sold for laboratory, research, or analytical purposes only not for human consumption, veterinary use, or medical applications
View insurance and pricing details
